Keudell/Morrison Wealth Management
Position in VKTX — Viking Therapeutics, Inc.
CIK 1785498
Salem, OR
Position in VKTX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$251,614
+$35,223 QoQ
Shares Held
6,450
-3.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#275
of 432 holders
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Keudell/Morrison Wealth Management holds $2,313,445 across 6 Biotechnology names. VKTX ranks #6 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KYMR |
Kymera Therapeutics, Inc.
|
5,215 | $598,004 | |
| 2 | ARGX |
Argenx SE
|
506 | $469,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
582 | $362,900 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,359 | $327,478 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
612 | $303,998 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
This page
|
6,450 | $251,614 |
All Filings in VKTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $251,614 | 6,450 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $216,391 | 6,650 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $209,321 | 5,950 | Shares | Sole | 2026-02-06 | |
| 2024-09-30 | $272,612 | 4,306 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $215,485 | 4,065 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $247,640 | 3,020 | Shares | Sole | 2024-05-07 | |
| No filing history on record for this holder in this stock. | ||||||